Výsledky vyhledávání

Akademický článek

A prospective, multicenter, randomized controlled trial comparing VDD-ICD with VVI-ICD in detecting subclinical atrial fibrillation in patients with ICDs: The Dx-AF trial.

Autor: Shurrab M; Department of Cardiology, Health Sciences North, Health Sciences North Research Institute, Northern Ontario School of Medicine University, Sudbury, Ontario, Canada., Janmohamed AK; Department of Cardiology, Scarborough Health Network, Toronto, Ontario, Canada., Ayala-Paredes FA; Department of Cardiology, Universite de Sherbrooke Medical School, Sherbrooke, Quebec, Canada., Sturmer M; Department of Cardiology, Sacre-Coeur Hospital, Université de Montréal, Montreal, Quebec, Canada., Toal SC; Department of Cardiology, NB Heart Centre, Saint John Regional Hospital, Saint John, New Brunswick, Canada., Sarrazin JF; Department of Cardiology, Quebec Heart and Lung Institute, Quebec City, Quebec, Canada., Thorpe KE; University of Toronto, Toronto, Ontario, Canada., Sterns LD; Department of Cardiology, Vancouver Island Arrhythmia, Victoria, British Columbia, Canada., Healey JS; Department of Cardiology, Hamilton Health Sciences, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada., Crystal E; Department of Cardiology, Sunnybrook and Women's College Hospitals, University of Toronto, Toronto, Ontario, Canada.

Publikováno v: Heart rhythm O2 [Heart Rhythm O2] 2024 Jul 23; Vol. 5 (9), pp. 668-671. Date of Electronic Publication: 2024 Jul 23 (Print Publication: 2024).

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Report

Extraction of a misplaced left ventricular pacing lead with complete embolic cerebral protection and intracardiac echocardiography visualization.

Autor: Butzke da Motta H; Division of Cardiology, Hôpital du Sacré-Cœur de Montréal, Université de Montréal, Montreal, Canada., Kouz R; Division of Cardiology, Hôpital du Sacré-Cœur de Montréal, Université de Montréal, Montreal, Canada., Sturmer M; Division of Cardiology, Hôpital du Sacré-Cœur de Montréal, Université de Montréal, Montreal, Canada., Hadjis A; Division of Cardiology, Hôpital du Sacré-Cœur de Montréal, Université de Montréal, Montreal, Canada., Becker G; Division of Cardiology, Hôpital du Sacré-Cœur de Montréal, Université de Montréal, Montreal, Canada., Cerantola M; Division of Cardiology, Hôpital du Sacré-Cœur de Montréal, Université de Montréal, Montreal, Canada.

Publikováno v: HeartRhythm case reports [HeartRhythm Case Rep] 2024 Feb 27; Vol. 10 (5), pp. 326-329. Date of Electronic Publication: 2024 Feb 27 (Print Publication: 2024).

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Standard vs Augmented Ablation of Paroxysmal Atrial Fibrillation for Reduction of Atrial Fibrillation Recurrence: The AWARE Randomized Clinical Trial.

Autor: Nair GM; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Birnie DH; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Nery PB; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Redpath CJ; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Sarrazin JF; IUCPQ, Québec City, Québec, Canada., Roux JF; CHUS-Sherbrooke, Sherbrooke, Québec, Canada., Parkash R; Queen Elizabeth II Health Sciences, Halifax, Nova Scotia, Canada., Bernier M; McGill University Health Center, Montreal, Québec, Canada., Sterns LD; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada., Sapp J; Queen Elizabeth II Health Sciences, Halifax, Nova Scotia, Canada., Novak P; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada., Veenhuyzen G; Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada., Morillo CA; Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada., Singh SM; Sunnybrook Health Sciences Center, Toronto, Ontario, Canada., Sadek MM; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Golian M; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Klein A; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Sturmer M; Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada., Chauhan VS; University Health Network, Toronto General Hospital, Toronto, Ontario, Canada., Angaran P; St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Green MS; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Bernick J; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Wells GA; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Essebag V; McGill University Health Center, Montreal, Québec, Canada.; Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada.

Publikováno v: JAMA cardiology [JAMA Cardiol] 2023 May 01; Vol. 8 (5), pp. 475-483.

Zobrazit plný text záznamu

Akademický článek

Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale.

Autor: Nery PB; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.. Electronic address: PNery@ottawaheart.ca., Wells GA; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.; Cardiovascular Research Methods Center, University of Ottawa Heart Institute, Ottawa, Canada., Verma A; McGill University Health Center, Montreal, Quebec, Canada., Joza J; McGill University Health Center, Montreal, Quebec, Canada., Nair GM; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada., Veenhuyzen G; Libin Cardiovascular Institute, University of Calgary, Calgary, Canada., Andrade J; Vancouver General Hospital, University of British Columbia,Vancouver, Canada., Nault I; Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Quebec City, Quebec, Canada., Wong JA; Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada., Sikkel M; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada., Essebag V; McGill University Health Center, Montreal, Quebec, Canada; Hôpital Sacré-Cœur, Université de Montréal, Montréal, Québec, Canada., Macle L; Montreal Heart Institute, Montreal, Québec, Canada., Sapp J; Queen Elizabeth II Health Sciences, Halifax, Nova Scotia, Canada., Roux JF; CHUS-Sherbrooke, Sherbrooke, Quebec, Canada., Skanes A; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Angaran P; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Novak P; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada., Redfearn D; Kingston General Hospital, Kingston, Ontario, Canada., Golian M; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada., Redpath CJ; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada., Sturmer M; Hôpital Sacré-Cœur, Université de Montréal, Montréal, Québec, Canada., Birnie D; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.

Publikováno v: American heart journal [Am Heart J] 2022 Dec; Vol. 254, pp. 133-140. Date of Electronic Publication: 2022 Aug 27.

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationale.

Autor: Nair GM; University of Ottawa Heart Institute, Ottawa, Canada., Birnie DH; University of Ottawa Heart Institute, Ottawa, Canada., Wells GA; University of Ottawa Heart Institute, Ottawa, Canada., Nery PB; University of Ottawa Heart Institute, Ottawa, Canada., Redpath CJ; University of Ottawa Heart Institute, Ottawa, Canada., Sarrazin JF; IUCPQ, Quebec, Quebec, Canada., Roux JF; CHUS-Sherbrooke, Sherbrooke, Quebec, Canada., Parkash R; Queen Elizabeth II Health Sciences, Halifax, Nova Scotia, Canada., Bernier M; McGill University Health Centre, Montreal, Quebec, Canada., Sterns LD; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada., Novak P; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada., Veenhuyzen G; Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada., Morillo CA; Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada., Singh SM; Sunnybrook Health Sciences Center, Toronto, Ontario, Canada., Sturmer M; Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada., Chauhan VS; University Health Network, Toronto General Hospital, Toronto, Ontario, Canada., Angaran P; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Essebag V; McGill University Health Centre, Montreal, Quebec, Canada; Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada.

Publikováno v: American heart journal [Am Heart J] 2022 Jun; Vol. 248, pp. 1-12. Date of Electronic Publication: 2022 Feb 24.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání